OmniAb

Provides antibody discovery technologies using proprietary transgenic animal platforms.

Founded 2012 · 114 employees · United States · Public

Listed:

NASDAQ: OABI

Subsidiaries:

Icagen, xCella Biosciences, Ab initio Biologics